Scinovex
Subscribe
M

Manisha H. Shah

The Ohio State University Wexner Medical Center (US)ORCID 0000-0002-6453-2044
h-index
64
Publications
322
Citations
34.2K
i10-index
162
Impact (2-yr)
2.63
Citations per year
Research Areas
Neuroendocrine Tumor Research AdvancesLung Cancer Research StudiesThyroid Cancer Diagnosis and TreatmentNeuroblastoma Research and TreatmentsCancer Immunotherapy and Biomarkers
Affiliations
Université Claude Bernard Lyon 1
FR · 2012–2012
Roche (Switzerland)
CH · 2017–2017
Mount Sinai Hospital
CA · 2006–2009
Roswell Park Comprehensive Cancer Center
US · 1997–2006
Nationwide Children's Hospital
US · 2000–2000
OncoMed (United States)
US · 2017–2017
Beth Israel Deaconess Medical Center
US · 2006–2006
Memorial Sloan Kettering Cancer Center
US · 2014–2020

Top Publications

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Journal of Clinical Oncology20192,871 citations
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
The Lancet Oncology20202,424 citations
Study of malaria cases in central laboratory at tertiary care hospital, Vadodara, India
International Journal of Clinical and Diagnostic Pathology20211 citations
Manisha H. Shah · Scinovex